Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate vs Ezetimibe Add-on to Atorvastatin in Combined Hyperlipidemia
NCT00195793Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Aug 2004
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of fenofibrate in combined hyperlipidemia (2 arms), sponsored by Abbott Laboratories. Primary endpoint: Percent change from Combination Baseline to 12 weeks post-Combination Baseline in direct measured HDL-C and TG. Started Aug 2004; status: completed.
02
Drugs
fenofibrate
03
Conditions
combined hyperlipidemia
Beyond the preview
Go deeper on NCT00195793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195793.